Search

everythinglearnresearchcommunity

for

Search:↓

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Majoon Ushba and Marham Gulabi effectively treat dermatophytosis.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Doublebase gel hydrates skin better and is preferred by most users over Aqueous cream.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

There is a significant need for better-validated quality of life tools in dermatology.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Biotin and biotinidase are essential to prevent health issues, and deficiencies require lifelong supplementation.

Computational techniques can improve drug development for treating certain conditions.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Alopecia areata greatly affects quality of life, needing psychological support.

The hydrogel quickly stops bleeding and helps heal infected wounds.

The document provides 70 multiple choice questions to improve haematology skills.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

PHMB products improve wound healing and quality of life.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.